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Predictors and outcomes of acute kidney injury
after thoracic aortic endograft repair
Gabriele Piffaretti, MD, PhD,a Giovanni Mariscalco, MD, PhD,b Stefano Bonardelli, MD,c
Antonio Sarcina, MD,d Guido Gelpi, MD,e Raffaello Bellosta, MD,d Maurizio De Lucia, MD,c
Franco Nodari, MD,c Edoardo Cervi, MD,c Gianpaolo Carrafiello, MD,f Carlo Antona, MD,e and
Patrizio Castelli, MD,a Varese, Brescia, and Milan, Italy
Background: This study analyzed the incidence and the predictive factors of postoperative acute kidney injury (AKI) after
thoracic endovascular aortic repair (TEVAR) and evaluated the effect of AKI on postoperative survival.
Methods: Between November 2000 and April 2011, all consecutive patients undergoing TEVAR of the descending
thoracic or thoracoabdominal aorta were enrolled at four teaching hospitals. Estimated glomerular filtration rate (eGFR)
was evaluated during the entire hospitalization. AKI was defined by the RIFLE (Risk, Injury, Failure, Loss of function,
End-stage renal disease) consensus criteria.
Results: The study included 171 patients (80% men) who were a mean age of 69  14 years (range, 18-87 years). AKI
occurred in 24 patients (14%). Independent predictors of postoperative AKI were preoperative depressed eGFR,
thoracoabdominal extent, and postoperative transfusion. Patients with AKI experienced major postoperative complica-
tions (P  .001), longer hospitalization (P  .008), and higher hospital mortality (29% vs 4%; P < .001). Kaplan-Meier
analysis showed a survival of 82%, 51%, and 51% at 1, 3, and 5 years for patients who developed AKI, which was
significantly worse than the 99%, 89%, and 80% for patients who did not experience AKI (P  .001).
Conclusions: Preoperative poor renal function, blood transfusions, and the thoracoabdominal extent of the aortic disease
were the most important predictors for AKI. (J Vasc Surg 2012;56:1527-34.)
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NThoracic endovascular aortic repair (TEVAR) has
emerged as an alternative method of treatment for thoracic
aortic diseases and is attractive for patients who would not
be ideal candidates for conventional surgery.1-3 Despite
advances in endograft techniques and postoperative care,
TEVAR is still associated with substantial morbidity and
mortality, and a disturbing number of patients still have
complicated courses.4 Similarly to conventional surgery,
multiple TEVAR complications have been reported. Al-
though cerebrovascular accidents, endoleaks, and retro-
grade dissection have been reported as major adverse out-
comes, acute kidney injury (AKI) has emerged as a serious
complication and harbinger of poor prognosis after endo-
vascular treatment of aortic aneurysms.5-9
The incidence of AKI after TEVAR and its effect on
postoperative survival have been poorly addressed in the
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http://dx.doi.org/10.1016/j.jvs.2012.05.106iterature. If we add the fact that TEVAR has also been
idely adopted in low-risk patients, we might expect a
ommensurate increase of AKI incidence.10 The aim of the
resent multicenter study was to analyze the predictive
actors of postoperative AKI after TEVAR and evaluate the
ffect on postoperative survival.
ETHODS
The protocol for this study was in compliance with the
nstitutional Review Board at the four participating teach-
ng hospitals and received full approval. All patients gave
heir consent to participate.
Patient population. Between November 2000 and
pril 2011, all consecutive patients undergoing TEVAR for
escending thoracic or thoracoabdominal aortic disease
ere enrolled. The study was designed as a prospective,
ulticenter experience with a retrospective data analysis.
he analysis excluded patients with preoperative dialysis or
ho died intraoperatively. All clinical and procedural data
ere prospectively collected and recorded onto a comput-
rized database registry that remained consistent during the
tudy period. Data entry was managed by physicians in-
olved in patient care. Information about demographics,
omorbidities, medical and surgical history, operative de-
ails, and postoperative events during the hospital stay were
ll registered.
Patient management. All elective patients underwent a
reoperative evaluation with transthoracic echocardiography.
omputed tomography (CT) angiography was performed
sing a 64-detector row (Aquilion-Toshiba, Zoetermeer, The
etherlands); initially, nonenhanced CT images were ob-
ained, then 80 to 90 mL (350 to 400 mg of iodine/mL) of
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December 20121528 Piffaretti et ala nonionic intravenous contrast material (Iomeron; Bracco,
Milano, Italy) were administered at a rate of 4 mL/s,
followed by a bolus of saline solution (40 mL) by using a
power injector (Envision CT Injector; Medrad, Pittsburgh,
Pa). Supra-aortic trunk and brain vessels were evaluated in
every patient scheduled to undergo arch debranching to
assess the integrity of the circle of Willis and the dominance
of the vertebral arteries. Most recently, the postprocessing
(multiplanar reconstructions, maximum intensity projec-
tions, three-dimensional images, and virtual angioscopy)
was performed on a workstation (Vitrea; Vital Images,
Plymouth, Minn).
Generally, patients who underwent elective TEVAR re-
ceived peri-interventional intravenous hydration with 0.9%
saline solutionwith adjunct of 600mgacetylcysteine (Fluimu-
cil; Zambon Italia, Vicenza, Italy). All potentially nephrotoxic
drugs were discontinued before the intervention. A specific
renal protective protocol was never used routinely.
All interventions were performed in an operating theater
fully equipped to perform conventional or endovascular pro-
cedures. A portable C-arm fluoroscopy system (OEC 9600;
OECMedical Systems, ThousandOaks, Calif; and Vision FD
Vario 3D; Ziehm, Reggio Emilia, Italy) with digital subtrac-
tion angiography and road map capabilities was used. Cere-
brospinal fluid drainage (Duet; Medtronic Vascular, Santa
Rosa, Calif) was not used routinely but selectively (extensive
aortic coverage, previous or synchronous abdominal aortic
repair). Transcranial Doppler (Acuson S2000; Siemens, Mi-
lano, Italy) was eventually performed in every case of arch
vessels debranching; specifically, arch debranching was per-
formed off-pump, without circulatory arrest and using tan-
gential clamping of the ascending aorta. In addition, intraop-
erative transesophageal echocardiography was used for
dissections but not routinely for aneurysms.
Briefly, intervention was performed under general anes-
thesia with orotracheal intubation and spinal or local anesthe-
sia. Short-term antibiotic prophylaxis with cefazolin (2 g,
twice daily) or vancomycin (1 g, twice daily) and endovenous
heparinization (40 U/kg) were administered routinely. Gen-
erally, TEVAR was carried out using surgical exposure of one
common femoral artery, and percutaneous contralateral fem-
oral, radial, or brachial accesses were used as needed.
Serum creatinine measurement before hospitalization
was available in all patients to identify those with AKI on
admission. A nonionic, hyposmolar contrast medium
(Visapaque 320; Amersham Sorin, Saluggia, Italy) was used
with an automated power injector. After TEVAR, patients
were transferred to a dedicated cardiovascular intensive care
unit when required. Heart rate, electrocardiogram, central
venous and arterial pressures, acid–base, and blood gases
were continuously monitored, as well as creatinine level and
estimated glomerular filtration rate (eGFR), for the first 3
days at least, during the intensive care unit stay or through-
out the entire hospitalization. Fluid intake and output were
monitored hourly throughout the hospital stay.
Perioperative need for blood products was determined on
an individual basis. In general, homologous packed red blood
cells (RBCs) were administered to maintain the hemoglobin eoncentration 8 g/dL. Four different devices were im-
lanted: Talent, Valiant, or Captivia (Medtronic Vascular,
anta Rosa, Calif); Excluder, TAG, or C-TAG (W. L. Gore
nd Assoc, Flagstaff, Ariz); TX-1 or TX-2 (Cook, Bloom-
ngton, Ind); and Endofit (LeMaitre Vascular Inc, Burling-
on, Mass). Endografts with bare stents were generally not
sed for traumatic aneurysms or dissections. Controlled
ypotension was used during the deployment of the en-
ograft. The proximal attachment site of the endograft was
outinely ballooned, except for selected cases.
Definitions. All variables analyzed in the study were
efined according to the Society of Thoracic Surgeons
dult Database definitions.11 Morphologic features and
utcomes were classified according to the Society for Vas-
ular Surgery/International Society for Cardiovascular
urgery reporting standards.12 The extent of the disease
as classified accordingly: lesions involving the descending
horacic alone were divided as described by Estrera et al.13
he thoracoabdominal extent followed the Crawford clas-
ification as modified by Safi and Miller.14 The proximal
anding zone of the endograft was defined following the
rch map described by Ishimaru in Criado et al.15 The
eBakey classification was used to categorize dissections.16
rading of the aortic arch atheroma was defined according
o a previously reported modified classification.6
AKI was defined by the RIFLE (Risk of renal dysfunc-
ion, Injury to the kidney, Failure of kidney function, Loss
f kidney function, and End-stage kidney disease) consen-
us criteria using the maximal change in serum creatinine
nd eGFR during the postoperative days compared with
aseline values before surgery.17
Risk means serum creatinine increased 1.5 times or
rine production of0.5mL/kg for 6 hours. Injury means
oubling of creatinine or urine production 0.5 mL/kg
or 12 hours. Failure means tripling of creatinine or creat-
nine 355 mol/L (with a rise of 44 [4 mg/dL]) or
rine output 0.3 mL/kg for 24 hours. Loss means per-
istent AKI or complete loss of kidney function for 4
eeks. End-stage renal disease means complete loss of
idney function for 3 months. Urinary output criteria in
efining AKI were not considered; eGFR was calculated
ith the Chronic Kidney Disease Epidemiology Collabora-
ion equation, which is more accurate than the Modifica-
ion of Diet in Renal Disease Study equation.18
Data analysis. Clinical data were prospectively re-
orded and tabulated with Excel software (Microsoft Corp,
edmond, Wash). Continuous variables were tested for
ormal distribution by the Kolmogorov-Smirnov test and
ompared between groups with unpaired Student t-test for
ormally distributed values; otherwise, the Mann-Whitney
test was used. In case of dichotomous variables, group
ifferences were examined by Pearson 2 or Fisher exact
ests as appropriate. A stepwise logistic regression model
as developed to identify patient and procedural variables
ssociated with AKI development. The model was built
sing variables that demonstrated a value of P  .25 in
nivariable mode. The significance within the model was
valuated with the Wald test, and the strength of the
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Volume 56, Number 6 Piffaretti et al 1529association of variables with AKI development was esti-
mated by calculating odds ratios (ORs) and 95% confidence
interval (CIs). The model was calibrated by the Hosmer-
Lemeshow goodness-of-fit test, as well as residual diagnos-
tics (deviance and df ); model discrimination was evalu-
ated by using the area under the receiver operating
characteristic (AUROC) curve. Kaplan-Meier estimates
and log-rank tests were performed for the mortality rate
comparison. Results are expressed as mean  standard
deviation for continuous variables and frequencies for cat-
egoric variables. All tests were two-sided with   0.05 for
statistical significance. Statistical analysis was computed
using SPSS 16.0 software (SPSS Inc, Chicago, Ill).
RESULTS
Population. The final study included 171 patients,
comprising 137 men (80%). Mean age was 69  14 years
(range, 18-87 years). Table I reports demographic data and
comorbidities. At baseline, a moderate reduction of the
eGFR 30 to 59 mL/min/1.73 m2 was present in 50
patients (29%), whereas 21 (12%) had a severely depressed
eGFR of 30 mL/min/1.73 m2. Thoracic endografting
was performed as an emergency in 48 patients (28%), and a
thoracic aortic rupture was observed in 33 (19%). Cerebro-
spinal fluid drainage was used in 21 patients (11.8%),
overall. Median operation time was 110 minutes (range,
Table I. Demographic data and comorbidities
Variablesa
Total No AKI AKI
P(N  171) (n  147) (n  24)
Demographic
Age, years 69  14 69  14 68  16 .868
BMI, kg/m2 26  4 26  4 26  4 .928
Male sex 137 (80) 117 (80) 20 (83) .789
Presentation
Emergency 48 (28) 40 (27) 8 (33) .536
Prior vascular
surgery 47 (26) 40 (27) 7 (29) .842
Rupture 33 (19) 28 (19) 5 (21) .786
CT delay 48 hours 59 (35) 50 (34) 9 (38) .739
Cardiac history
Coronary artery disease 46 (27) 40 (27) 6 (25) .821
LVEF, % 55  9 55  8 56  11 .774
Comorbidities
Hypertension 139 (81) 119 (81) 20 (83) .999
Diabetes 14 (8) 12 (8) 2 (8) .978
COPD 62 (36) 49 (33) 13 (54) .049
eGFR class, mL/min/
1.73m2 .001
Good, 60 100 (59) 90 (61) 10 (42)
Fair, 30-59 50 (29) 46 (31) 4 (17)
Depressed, 30 21 (12) 11 (8) 10 (42)
EuroSCORE logistic (%) 22  20 21  19 30  25 .056
AKI, Acute kidney injury; BMI, body mass index; COPD, chronic obstruc-
tive pulmonary disease;CT, contrast tomography; eGFR, estimated glomer-
ular filtration rate; EuroSCORE, European System for Cardiac Operative
Risk Evaluation; LVEF, left ventricular ejection fraction.
aContinuous data are expressed as mean standard deviation and categoric
data as number (%).20-600 minutes). tMain features of the thoracic disease are listed in Table
I. Pathologies included atherosclerotic aneurysm (64%),
enetrating aortic ulcer/intramural hematoma (15%),
omplicated acute dissection or chronic dissecting aneu-
ysm (12%), and trauma (9%). Descending thoracic aorta
as the predominant location (73%) of the disease.
The thoracoabdominal aneurysms involved the renal
rteries in three patients. All were Crawford extent II
neurysms (two developed over a previous dissection:
eBakey extent 3 and 3b accordingly to Reul-Cooley). All
ere revascularized during the hybrid intervention. The
ean renal ischemia time was 24 minutes. We did not use
ranched or fenestrated endografts or ancillary technique,
uch as snorkel, sandwich, or double-barrel technique.
Primary technical success was 95%. Additional vascular
rocedures were required in 44% (Table III). Postopera-
ively, 26% required RBCs transfusion. Hospital mortality
as 8% (13 of 171): causes of death included cardiogenic
hock in four, stroke in three, multiple organ failure in
hree, and one patient each died of acute retrograde type A
ortic dissection, acute myocardial infarction, or respiratory
nsufficiency.
AKI incidence and predictors. The AKI rate during
ospitalization was 14% (24 of 171 patients). RIFLE class
accounted for six patients (3.5%), RIFLE class I for four
2.3%), and RIFLE class F for 14 (8.2%). Six patients
3.5%) required renal replacement therapy. The incidence
f AKI did not differ among centers (P  .163), and a
ignificant reduction (P  .044) was observed throughout
he years (Fig 1). Patients were comparable in demographic
ata and comorbidities (Table I); only eGFR functional
lasses (P  .001) and chronic obstructive pulmonary
isease (P  .049) differed between the two groups. Pa-
able II. Thoracic aortic lesion details
ariablesa
Total No AKI AKI
P(N  171) (n  147) (n  24)
izing
Extension, cm 10 (6-18) 10 (6-18) 12 (7-25) .227
Diameter, cm 6 (4-8) 6 (4-8) 7 (6-18) .036
tiology .177
Atherosclerotic 109 (64) 90 (61) 19 (79)
Dissection 20 (12) 19 (13) 1 (4)
PAU/IMH 26 (15) 25 (17) 1 (4)
Traumatic 16 (9) 13 (9) 3 (13)
ocation .005
Arch 33 (19) 29 (20) 4 (17)
Descending thoracic 124 (73) 110 (75) 14 (58)
Thoracoabdominal 14 (8) 8 (5) 6 (25)
theroma degree .275
Normal 97 (57) 81 (55) 16 (67)
3 mm 52 (34) 48 (33) 4 (17)
3-5 mm 18 (11) 14 (10) 4 (17)
5 mm 4 (2) 4 (2) —
KI, Acute kidney injury; IMH, intramural hematoma; PAU, penetrating
ortic ulcer.
Data for continuous variables are shown as median (25th-75th percentile),
nd data for categoric variables are shown as number (%).ients affected by AKI had thoracic aneurysm with a larger
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December 20121530 Piffaretti et aldiameter (P  .036), predominantly involving the thora-
coabdominal aorta (25% vs 5%; P  .005). No differences
were observed in etiology (P  .177) and arch atheroma-
tous overload (P  .275). Also similar between groups
were endograft diameter (P  .464), length of aortic
coverage (P  .23), number of endografts implanted (P 
.383), and intervention duration (184 164 vs 139 101
min; P .073). Contrast material (168 136 vs 130 66
mL; P  .033) and rate of the RBCs transfusion (54% vs
21%; P  .001) were significantly higher in those who
developed AKI. The dose for those patients with a de-
pressed eGFR was a mean 134  6 mL (median, 120 mL;
range, 40-350 mL).
Multivariable analysis identified depressed eGFR (OR,
Table III. Perioperative, procedural, and postoperative da
Variablesa
Total
(N  171)
Perioperative data
Operation time, minutes 110 (70-180)
Bleeding, mL 110 (50-311)
Contrast medium, mL 120 (80-160)
Associated vascular surgery 50 (29)
Adjunctive procedures 75 (44)
Primary success 163 (95)
Endograft characteristics
Diameter, mm 36 (34-40)
Coverage length, mm 20 (15-20)
Endografts, No. 1 (1-2)
Postoperative data
Major SVS morbidity 0 (0-2)
RBCs transfusion 44 (26)
RBCs units, No. 0 (0-1)
Length of stay, days
Intensive care unit 94 (55)
Hospital 7 (5-14)
Hospital mortality 13 (8)
AKI, Acute kidney injury; RBCs, red blood cells; SVS, Society for Vascular
aData for continuous variables are shown as median (25th-75th percentile),
Fig 1. Annual performance of thoracic endovascular aneurysm
repair and rate of acute kidney injury (AKI).16.06; 95% CI, 4.34-59.42), postoperative need of RBCs 8ransfusion (OR, 1.35; 95% CI, 1.07-1.70), and thoraco-
bdominal extent (OR, 6.63; 95% CI, 1.11-39.56) of the
ortic disease (Table IV) as independent predictors of post-
perative AKI, but not age (OR, 0.98; 95% CI, 0.94-1.02)
r contrast material (OR, 1.00; 95% CI, 0.99-1.01). Re-
arding the thoracoabdominal extent of the disease, the
ean operative time was 329  186 minutes, and contrast
olume was 211  156 mL. The correlation between
neurysm extent, operative time, and contrast load was not
ignificant at multivariable level (aneurysm extent 	 oper-
tive time 	 contrast medium; P  .089).
The Hosmer-Lemeshow goodness-of-fit test (25 
.18; P  .824) and ROC analysis (AUROC, 0.85) re-
ealed good calibration and discrimination for the obtained
ultivariable model. Fig 2 displays the probability of AKI
ccurrence in relation to the number of transfused blood
nits, basal renal function (expressed as basal eGFR), and
horacoabdominal extent of the disease.
Hospital and survival outcomes. Patients who devel-
ped postoperative AKI experienced major postoperative
omplications (Society for Vascular Surgery morbidity
core 3  3 vs 1  2; P  .001), longer hospitalization
27  36 vs 12  16 days; P  .008), and higher hospital
ortality (29% vs 4%; P  .001). Postoperative AKI was
lso confirmed at multivariable analysis as an independent
redictor for hospital death (OR, 13.03; 95% CI, 2.39-
7.83). Follow-up was completed for all patients dis-
harged alive, with a mean of 25 months (median, 15;
ange, 3-98 months). No patients required temporary or
ermanent dialysis. Kaplan-Meier analysis revealed a re-
uced survival for patients affected by AKI compared with
atients without this postoperative complication (Fig 3).
aplan-Meier analysis showed an unfavorable survival of
No AKI AKI
P(n  147) (n  24)
100 (70-180) 120 (71-270) .073
100 (30-300) 250 (100-800) .285
120 (80-160) 135 (85-195) .033
42 (27) 8 (33) .634
66 (45) 9 (38) .498
142 (97) 21 (86) .085
36 (34-38) 37 (34-40) .464
17 (15-20) 20 (14-24) .23
1 (1-2) 1 (1-2) .383
0 (0-1) 2 (0-4) .001
31 (21) 13 (54) .001
0 (0-0) 2 (0-4) .001
77 (52) 17 (71) .092
7 (5-12) 16 (7-34) .008
6 (4) 7 (29) .001
ry.
ata for categoric variables are shown as number (%).ta
Surge2% 9%, 51% 9%, and 51% 9% at 1, 3, and 5 years for
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Volume 56, Number 6 Piffaretti et al 1531patients who experienced AKI compared with 99% 0.8%,
89%  4%, and 80%  6% for patients without postopera-
tive AKI (P  .001).
DISCUSSION
The most important features of our study are the accu-
rate evaluation of the AKI development using the favorite
diagnostic tool to evaluate the severity and progression of
AKI, along with the identification of RBCs transfusion, a
depressed eGFR, and the thoracoabdominal extent of aor-
tic disease as independent predictive factors of AKI.
AKI has been regarded as a marker of increased early or
late morbidity and mortality in several experiences of con-
ventional repair for thoracoabdominal aneurysms and dis-
sections.19 In contrast, the incidence and predictors of AKI
after TEVAR have not been adequately analyzed even
though it has been frequently considered a potential inher-
ent complication of endovascular procedures.20-22 Up-to-
date specific data are still lacking for different reasons:
comparisons among studies are difficult because of the
differences among patient populations, heterogeneous eti-
ology, extent of the aortic pathologies, and most impor-
tantly, because the definitions of postoperative AKI are
Table IV. Predictors of acute kidney injury (all RIFLE
classes)
Variable OR (95% CI) P
Independent predictors
RBC unit 1.35 (1.07-1.70) .011
eGFR classa .001
Fair (30-59) 1.42 (0.37-5.44) .612
Poor (30) 16.06 (4.34-59.42) .001
Locationb .097
Descending thoracic 1.64 (0.43-6.22) .469
Thoracoabdominal 6.63 (1.11-39.56) .038
Other tested variables (NS)
Primary success 0.19 (0.23-1.71) .141
COPD 2.77 (0.70-10.93) .145
Year of procedurec 0.87 (0.67-1.12) .276
Operation timec 0.99 (0.99-1.00) .331
Contrast mediumc 1.00 (0.99-1.02) .543
Logistic EuroSCOREc 0.99 (0.95-1.02) .447
Aneurysm diameter 1.01 (0.98-1.05) .554
Aneurysm etiologyd .587
Dissection 0.43 (0.03-5.61) .520
PAU/IMH 0.25 (0.02-3.17) .282
Traumatic 0.12 (0.01-6.59) .298
Endograft coverage lengthc 0.99 (0.86-1.14) .852
Aneurysm extensionc 0.99 (0.89-1.11) .947
AKI, Acute kidney injury; CI, confidence interval; COPD, chronic obstruc-
tive pulmonary disease; eGFR, estimated glomerular filtration rate;
EuroSCORE, European System for Cardiac Operative Risk Evaluation;
IHM, intramural hematoma; NS, not significant; OR, odds ratio; PAU,
penetrating aortic ulcer;RBC, red blood cell;RIFLE, Risk of renal dysfunc-
tion, Injury to the kidney, Failure of kidney function, Loss of kidney
function, and End-stage kidney disease.
aeGFR class 60 mL/min/1.73 m2 as a reference group.
bAortic arch as a reference group.
cTested as continuous variables.
dAtherosclerotic as a reference group.different, with inevitable confounding effects.5,10,19-26 We tdopted the RIFLE classification, which has recently emerged
s the favorite diagnostic tool for monitoring the severity and
rogression of AKI after cardiothoracic surgery.17,18,27
There are several plausible explanations for the predict-
ng role of blood transfusion. First, in physiologic response,
BCs transfusion elicits an inflammatory response by direct
nfusion of inflammatory mediators and through an inten-
ification of the inflammatory process that further amplifies
he inflammatory stress related to TEVAR.27 The patho-
ogic role of interstitial inflammation and the release of
roinflammatory cytokines, as well as reactive oxygen spe-
ies, has been repeatedly demonstrated in the development
f tubular injury.27
Second, postoperative AKI may be correlated to the
igh proportion of procedures performed as emergencies.
n interesting observation in our experience has been that
mergency interventions were not associated with AKI
evelopment. A plausible explanation is related to the strict
elationship between emergency status and blood transfu-
ions, especially in case of complicated TEVAR such as
upture of the aortic lesions.28 Therefore, emergency status
s an independent AKI predictor could be certainly over-
helmed by the transfusion requirement.
Preoperative renal impairment, defined as depressed
GFR class, was not a surprising result. Wang et al23 used a
imple estimation of the renal function to confirm that a
aseline creatinine level of 2 mg/dL was predictive of
ostoperative AKI. Pisimisis et al,26 adopting the eGFR as
stimation of baseline renal function, observed that a de-
ressed preliminary eGFR was correlated with the deterio-
ation of renal function in the postoperative period. Only
ggebrecht et al22 partially disagreed with these findings.
hey observed that preliminary chronic kidney insuffi-
iency was an independent predictor only for postoperative
ialysis requirement. In this latter experience, it is possible
o observe a subtle difference between the categories in
hich the cohort was divided, suggesting that eGFR could
ave been more useful to predict AKI also in that experi-
nce.22 Therefore, considering the role of basal eGFR on
ostoperative AKI development, we suggest that renal
unction should be finely assessed in the preoperative phase
eing TEVAR exposed to potential detrimental factors.
his is to optimize the stratification for patients at risk and
o form the basis for a dedicated risk score, as in conven-
ional surgery.29
Another predictor for AKI that emerged from our
nalysis was the thoracoabdominal extent of the aortic
isease. This is extremely important in clinical practice and
eserves some comments. It would seem that the larger the
iameter and the extent of the disease, the greater the
ossibility that AKI will be a postoperative complication.
ur data are confirmed by other previous experiences: if
e consider descending thoracic lesions, the reported
ncidence of AKI ranged between 1% and 5%.2,5,21 The
otable experience of Marrocco-Trischitta et al10 de-
ected 2.8% of patients with postoperative AKI who
ecovered without dialysis. Conversely, if we consider
he thoracoabdominal extent of the aortic disease, the
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hybrid or totally endovascular).24
In the largest-ever report of hybrid visceral revascular-
ization for thoracoabdominal aneurysms, Drinkwater et
al30 compiled 107 patients and observed 26% who re-
quired hemofiltration in the immediate postoperative pe-
riod and up to 3.7% who required long-term dialysis. A
similar finding was also observed after a total endovascular
repair for thoracoabdominal lesions: AKI still occurred in
6% to 30% of the patients, even in the most renowned
Fig 2. Predicted probability of postoperative acute kidn
sion. eGFR, Estimated glomerular filtration rate.
Fig 3. Kaplan-Meier estimation of survival in patients with and
without acute kidney injury (AKI).centers.24,31,32 Our study is in consonance with results oeported by Drinkwater et al,30 who defined thoracoab-
ominal disease as the most limiting factor in achieving
ower rates of morbidity and mortality. The 14% of AKI
bserved in our experience could be considered higher than
hose previously cited. There are several reasons that poten-
ially explain this result; among them, some patients had a
epressed eGFR preoperatively. Forbes et al,33 in their
xtensive (the largest ever reported) experience, clearly
tated that preoperative renal dysfunction is a predictor of
orbidity and death.
Our experience is in consonance with that stated by
rinkwater et al30: although visceral rerouting does not
equire thoracotomy and thoracic aortic cross-clamping or
xtracorporeal circulation, the technique is burdened by
everal potential operative risks and is not a “rapid” opera-
ion. Most of our thoracoabdominal lesions did not involve
he renal arteries, but a visceral bypass on the hepatic or
uperior mesenteric artery, or both, was performed in a
arge proportion of them. The hybrid approach is a lengthy
peration, with potential important blood loss and, poten-
ially, hypoperfusion during the intervention. All of these
easons could be argued as part of the etiopathogenesis of
ostoperative AKI for those lesions involving the thoraco-
bdominal aorta.
Another potential reason is that some groups may not
ave included thoracoabdominal extent in their analysis, a
esion that we deliberately included in our analysis to depict
veryday reality andmake the analysis useful in termsof clinical
ractice. In addition in our experience, the length of the aorta
overed with the endografts, the duration of the intervention,
nd contrastmaterialwere not independent predictors ofAKI.
s noted, it is possible that the above-mentioned factors were
jury (AKI) according to red blood cell (RBC) transfu-ey inverruled by the thoracoabdominal lesion location.
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Volume 56, Number 6 Piffaretti et al 1533Our study reports a relatively low incidence of AKI
(14%) after TEVAR compared with previous published
experiences.2,5,21 We should take into account that a num-
ber of these studies were not been primarily focused on
AKI; in contrast, significant findings have been recognized
in those focused on this topic.22-26
● The first large experience was reported by Eggebrecht
et al,22 who registered a 34% rate of postoperative AKI,
with the highest rate observed in patients with preop-
erative chronic kidney insufficiency.
● Perioperative dialysis was required in 21% in the Wang
et al23 experience. They identified the degree of renal
impairment as themost important factor to predict this
complication.
● The most recent experience was published by Pisimisis
et al,26 who observed an 11.4% rate of acute decrease of
eGFR. This is apparently the lowest reported rate of
postoperative renal impairment. The authors argued that
their low AKI rate was potentially correlated to the de-
creased use of contrast material and extensive intravascu-
lar ultrasound imaging during the procedures.
We noted a significant reduction of AKI among these
three experiences: it seems reasonable that surgical outcomes
will improve with experience and the increasing number of
treated cases.34 Similarly, although our study is not sufficient
to permit a definitive learning curve analysis in our experience,
we documented a significant progressive reduction of AKI
over the years in all the participating centers.
Another important—and also disturbing—result that
emerged from our analyses is the persisting substantial
in-hospital mortality and the strong negative impact of AKI
on early outcomes such as hospital stay and survival.13,20,22
Postoperative AKI was here associated with a fivefold to
sixfold increased risk of hospital death and with 5- to
10-day increase in total hospital length of stay. This is in
line with the data of Wang et al23: in their experience,
patients with AKI had a statistically significant higher rate
of major adverse events after TEVAR, mainly cardiovascu-
lar accidents, such as stroke and myocardial infarction, that
ultimately resulted in a significant increase in death. AKI
also negatively influenced late survival in our study. These
data could be of top significance and should be taken into
account carefully when the operative risk stratification is
assessed and in weighing the usefulness of TEVAR as a
life-saving intervention.
The present study has some limitations. Mainly, our
study design is retrospective, although the data were pro-
spectively collected, certainly, including potential con-
founding variables. Secondly, the study is also statistically
limited because of the small number of patients enrolled.
We did not control for the possible nephroprotective effect of
preoperative statin therapy, although almost every patient in
our experience was receiving statin treatment. Finally, the
association between AKI and latemortality does not necessar-
ily indicate a causative effect, although studies on the general
population affected by chronic renal dysfunction suggest a
possible AKI effect due to volume overload, dialysis catheternsertion, and impaired host immunity and infections, which
ccompanied these patients.27
Our study does not provide results of autopsy exami-
ations, and only all-cause mortality was considered. In
ddition, our data did not document postdischarge new
ecurrence of AKI or dialysis requirement, being limited to
he hospital period only. However, a similar design is
resent in other studies, and our results are in consonance
ith them.10,22,23,25,26
ONCLUSIONS
In our experience, a preoperative depressed renal func-
ion, the thoracoabdominal extent of the aortic disease, and
lood transfusion requirement were the most relevant pre-
ictive factors of AKI after TEVAR. AKI increased early
orbidity and mortality rates; in addition, it is noteworthy
hat AKI was also associated with increased late mortality.
e hope that this analysis will herald larger studies that may
llow more accurate risk stratification of TEVAR to opti-
ize indications and be helpful in clinical practice.
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